10 October 2023
10 October 2023
Increasing mental health awareness is yet to improve clinical trial recruitment strategies for patients with mental health disorders.
The revised transparency rules and CTIS’s public portal are expected to be finalised in Q4 2024.
The partnership builds on their existing drug discovery agreement to develop a neurological disease target.
Kynomycin is designed to target complex skin and soft tissue infections caused by bacteria.
Limmatech, a GSK spinoff focused on combatting antimicrobial resistance, had sought series A funding seven years after foundation.
The trial's primary endpoint of clinical remission was achieved in 28% of patients who received 60mg of VTX002.
The governmental agency will fund research to find treatment for ALS patients who are not eligible for trials.
Evaluating MBX 1416's tolerability and safety are the primary endpoints of the study.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
